Related Experiment Videos
A68930: a potent agonist specific for the dopamine D1 receptor
J W Kebabian1, M P DeNinno, R Schoenleber
1Neuroscience Research Division, Abbott Laboratories, Abbott Park, IL 60061.
Neurochemistry International
|March 1, 1992
Summary
A novel compound, A68930, acts as a potent dopamine D1 receptor agonist in rat models. It also shows weak D2 receptor activity and induces prolonged turning behavior in lesioned rats.
Area of Science:
- Neuropharmacology
- Dopamine receptor research
Background:
- Dopamine receptors (D1 and D2) are crucial in regulating motor control and other neurological functions.
- Understanding the selective activity of compounds at these receptors is key for developing new therapeutics.
Purpose of the Study:
- To characterize the pharmacological profile of A68930 at dopamine D1 and D2 receptors.
- To evaluate the in vivo effects of A68930 in a rodent model of dopaminergic dysfunction.
Main Methods:
- In vitro biochemical assays to determine EC50 values at D1 and D2 dopamine receptors.
- In vivo behavioral testing in rats with unilateral 6-OHDA lesions to assess turning behavior.
Main Results:
- A68930 demonstrated potent full agonism at the D1 dopamine receptor (EC50 = 2.1 nM) in rat caudate-putamen.
- A significantly weaker full agonism was observed at the D2 dopamine receptor (EC50 = 3,920 nM).
- A68930 induced prolonged contralateral turning (> 20 hr) in rats with nigro-neostriatal lesions.
Conclusions:
- A68930 is a highly selective and potent D1 dopamine receptor agonist.
- Its ability to induce turning behavior suggests potential in models of Parkinson's disease or other conditions involving dopamine deficiency.